会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明专利
    • SUPPRESSANT FOR REDUCTION IN CEREBRAL GANGLIOSIDE CONTENT
    • JPH09315981A
    • 1997-12-09
    • JP16065496
    • 1996-05-31
    • SNOW BRAND MILK PROD CO LTD
    • MATSUBARA NORINOBUYANAGIDAIRA SHUICHIIKEUCHI YOSHIHIROYABE KYOKOAOE SEIICHIRO
    • A23L1/30A61K31/70A61K31/7032A61P25/28A61P43/00C07H7/027
    • PROBLEM TO BE SOLVED: To prepare the subject suppressant, comprising a sialyllactose (salt) as an active ingredient and useful for improving cerebropathy, etc., caused by a reduction in an intracerebral ganglioside content in the aged due to its ability to suppress the reduction in the intracerebral ganglioside content and improve the cerebral function. SOLUTION: This suppressant for a reduction in intracerebral ganglioside content comprises a sialyllactose or its salt as an active ingredient. A sialyllactose derived from a milk is preferred as the sialyllactose. The sialyllactose is obtained by treating a whey discharged when producing, e.g. a cheese with an ultrafiltration membrane, removing proteins, then treating the resultant whey with a simulated moving bed type chromatographic separator, providing a fraction containing about 5wt.% silalyllactose, subsequently concentrating the prepared fraction, then treating the concentrate with an anion exchange resin, further desalting the treated concentrate according to an electrodialysis, concentrating the resultant substance under a reduced pressure and subsequently freeze-drying the obtained concentrate. The ob jective suppressant is preferably perorally administered. The sialyllactose in a daily dose of 30-100mg/kg body weight for an adult is preferably ingested in order to manifest the suppressing effects on the reduction in the intracerebral ganglioside content.